一品紅(300723.SZ):鹽酸克林黴素膠囊獲得藥品註冊證書
格隆匯8月6日丨一品紅(300723.SZ)宣佈,公司子公司廣州一品紅製藥有限公司於近日收到國家藥品監督管理局核准簽發的《藥品註冊證書》。藥品通用名稱為鹽酸克林黴素膠囊(英文名/拉丁名:Clindamycin Hydrochloride Capsules),主要成分為鹽酸克林黴素。
鹽酸克林黴素膠囊劑適用於由敏感厭氧菌引起的嚴重感染和由鏈球菌、肺炎球菌和葡萄球菌等敏感菌株引起的嚴重感染,但僅適用於對青黴素過敏的患者或經醫生判斷不宜使用青黴素的患者。其適用人羣包括成人和兒童患者(能吞服膠囊)。根據米內網數據,2018年鹽酸克林黴素(口服產品)在公立醫院實現銷售規模為8.80億元,同比增長2.80%。
鹽酸克林黴素膠囊在國內已進入醫保甲類、基藥目錄;該次公司按照2016年化學藥品註冊分類改革方案中新註冊分類申報,視同通過一致性評價,其中,公司鹽酸克林黴素膠囊300mg規格為獨家通過藥品註冊產品。
公司表示,此次獲得鹽酸克林黴素膠囊3種品規的註冊證書,進一步豐富了公司產品品類,增強公司在抗感染領域的競爭力。公司將做好產品的市場準入、推廣、銷售等工作,為公司發展帶來新的增長機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.